RenovoRx, Inc. (NASDAQ:RNXT)
| Market Cap | 59.92M+12.0% |
| Revenue (ttm) | 1.98M+198.5% |
| Net Income | -12.29M-15.2% |
| EPS | -0.32+17.9% |
| Shares Out | 45.05M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 19,805 |
| Open | 1.34 |
| Previous Close | 1.37 |
| Day's Range | 1.33 - 1.35 |
| 52-Week Range | 0.70 - 2.59 |
| Beta | 0.97 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About RNXT
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$RNXT stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in RNXT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by RNXT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
RNXT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New RNXT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to RNXT from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in RNXT
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $2.29M |
| VXFVanguard Extended Market ETF | $772.81K |
Estimated from each fund’s disclosed top holdings × AUM
RNXT Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from RNXT’s recent data — informational, not investment advice